Summary:
The purpose of this study is to compare the effects of a study drug, obicetrapib to find out if obicetrpib is helpful for treating ASCVD and reducing the risk of major cardiovascular events when taken with your existing medication.
Criteria:- ≥18 years of age
- Have a history of ASCVD, defined by at least 1 of the following conditions:
- Coronary artery disease
- MI;
- Prior coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting); or
- Angiographic or computed tomography (CT) imaging (eg, multidetector CT or CT angiography) evidence of coronary atherosclerosis with >70% stenosis in at least 1 major epicardial coronary artery.
- Cerebrovascular disease
- Peripheral arterial disease
- Are on maximally tolerated lipid-modifying therapy
Qualified Participants May Receive:
You will be paid for the visits you complete according to the following schedule:
$75.00 per each completed in office visit.